Ozempic can curb alcohol cravings, study finds
Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
What happened
Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and consumption in a small trial involving people with moderate alcohol use disorder, researchers reported Wednesday in the journal JAMA Psychiatry. It was the first randomized controlled trial to study the effects of semaglutide on alcohol addiction, though anecdotal evidence and observational and animal studies have suggested the drug curbs desire for alcohol as well as food.
Who said what
The federally funded study gave 48 adults with signs of alcohol use disorder small doses of either semaglutide or a placebo once a week for nine weeks. Those receiving the semaglutide shots consumed significantly less alcohol on the days they drank versus the control group, though both groups drank about the same number of days each week.
"We hoped to see a reduction in drinking and craving," said study lead author Dr. Christian Hendershot of the USC Institute for Addiction Science. But the "magnitude of the effects" was unexpectedly good compared to the three little-used FDA-approved medications for alcohol use disorder. Semaglutide is already popular, and the finding that it helped people drink less could boost treatment uptake, addiction psychiatrist Dr. Raymond Anton said to CNN. "Most people seeking treatment do not want a goal of abstinence for the rest of their lives."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What next?
Several larger studies are underway on semaglutide and alcohol, plus the drug's effects on "smokers, people with opioid addiction and cocaine users," The Associated Press said. It's unclear how safe semaglutide "would be for a person of normal weight."
-
The UK’s supposed Christian revivalThe Explainer Research has shown that claims of increased church attendance, particularly among young people, ‘may be misleading’
-
How long can Keir Starmer last as Labour leader?Today's Big Question Pathway to a coup ‘still unclear’ even as potential challengers begin manoeuvring into position
-
Child-free train carriages: has push for adults-only spaces gone too far?Talking Point Under-12s ban on premium commuter train carriages in France sparks backlash across the political divide
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Stopping GLP-1s raises complicated questions for pregnancyThe Explainer Stopping the medication could be risky during pregnancy, but there is more to the story to be uncovered
-
Obesity drugs: Will Trump’s plan lower costs?Feature Even $149 a month, the advertised price for a starting dose of a still-in-development GLP-1 pill on TrumpRx, will be too big a burden for the many Americans ‘struggling to afford groceries’
-
Tips for surviving loneliness during the holiday season — with or without peoplethe week recommends Solitude is different from loneliness
-
More women are using more testosterone despite limited researchThe explainer There is no FDA-approved testosterone product for women
-
Climate change is getting under our skinUnder the radar Skin conditions are worsening because of warming temperatures
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
